Please ensure Javascript is enabled for purposes of website accessibility

A Chemical Romance With Rohm & Haas

By Stephen D. Simpson, Simpson, – Updated Nov 15, 2016 at 6:36PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Costs and new capacity shouldn't be ignored, but there could still be an upside for this chemicals company.

OK, now I get it. Rohm & Haas (NYSE:ROH) seems frequently conservative (if not slightly dour) with its guidance. Yet -- recently, at least -- it still manages to surpass that guidance. What's more, there might still be a chance here to nail some bear pelts to the wall.

Since the company preannounced guidance, there were few surprises in the earnings report itself. Revenue was up 3%, but gross margins expanded a full point, and operating margins expanded even more. That drove better-than-13% growth in operating income, while lower interest expenses, taxes, and unusual expenses drove a 30% improvement in reported net income.

There are a lot of moving parts here, so I won't be talking about all of them. Instead, I'll focus mostly on the monomers and electronic-materials businesses. The monomers business seems to have some folks worried these days -- mostly of the threat of added capacity in the acrylic/acrylate markets. And it's true that revenue was down a little this quarter. But here's the thing -- the majority of sales in this business go to other Rohm and Haas units, so lower prices here just mean better margins in businesses like coatings and performance chemicals.

Electronic materials are unquestionably strong. Revenue was up 24%, and reported earnings doubled on strength in both semiconductors and packaging/finishing technologies. And while this business is obviously sensitive to changing technologies, Rohm and Haas has kept pace with the likes of Cabot Microelectronics (NASDAQ:CCMP).

There's no shortage of stock ideas playing into the chemicals industry -- whether you're talking broadly diversified companies like DuPont (NYSE:DD) and Dow (NASDAQ:DOW) or more specialized players like Cytec (NYSE:CYT) and Sherwin-Williams (NYSE:SHW). Though it's wise to keep an eye on energy costs and remember that these companies often make for questionable long-term holdings, I wouldn't break off a relationship with Rohm and Haas just yet.

For more chemical-loaded Foolishness:

Dow is a Motley Fool Income Investor pick. Don't delay -- dive deep into dynamic dividend-paying stocks with a free 30-day guest pass.

Fool contributor Stephen Simpson has no financial interest in any stocks mentioned (that means he's neither long nor short the shares).

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

E. I. du Pont de Nemours and Company Stock Quote
E. I. du Pont de Nemours and Company
DD
The Sherwin-Williams Company Stock Quote
The Sherwin-Williams Company
SHW
$211.22 (1.52%) $3.17
Cabot Microelectronics Corporation Stock Quote
Cabot Microelectronics Corporation
CCMP

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.